Literature DB >> 3886192

Abnormalities of serum and plasma components in patients with multiple sclerosis.

H C Ford.   

Abstract

Qualitative and quantitative abnormalities in protein and non-protein components of serum and plasma in patients with multiple sclerosis have been the subjects of numerous reports. In this review many of the more recent observations are documented and evaluated. It is concluded that at present the welter of information that has been gathered does not contribute in any major, coherent way to our understanding of the etiology or pathogenesis of the disorder. Several of the abnormalities that have been observed may be future candidates for biochemical markers for multiple sclerosis; at present none is sufficiently reliable, distinctive or easily performed to warrant the status of a useful diagnostic or prognostic test.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886192      PMCID: PMC7130298          DOI: 10.1016/s0009-9120(85)80016-3

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  142 in total

1.  Abnormalities in native and dissociated alpha 2-macroglobulin isolated from multiple sclerosis serum.

Authors:  S C Rastogi; J Clausen
Journal:  Clin Chim Acta       Date:  1980-10-23       Impact factor: 3.786

2.  Serum alkaline phosphatase in patients with multiple sclerosis.

Authors:  S S Papiha; D F Roberts
Journal:  Clin Genet       Date:  1975-01       Impact factor: 4.438

3.  Elevated antibody levels against measles virus P protein in sera of patients with multiple sclerosis.

Authors:  S L Wechsler; H C Meissner
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

4.  Preparation of antisera directed against the idiotype(s) of immunoglobulin G from the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  L M Nagelkerken; R C Aalberse; H K van Walbeek; T A Out
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

5.  Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases.

Authors:  W C Love; A Cashell; M Reynolds; N Callaghan
Journal:  Br Med J       Date:  1974-07-06

6.  The leukocyte adherence-inhibition assay as a diagnostic test for multiple sclerosis: study of a substance found in MS blood.

Authors:  J W Angers; L Korik; L S Franklin; W E Reid; C Urbania; R Turner; A H Angers; S Soviero; M Lyons; A L Levy
Journal:  J Lab Clin Med       Date:  1979-04

7.  Abnormal serum alpha 2-macroglobulin in multiple sclerosis.

Authors:  S C Rastogi; J Clausen; T Fog
Journal:  Eur Neurol       Date:  1981       Impact factor: 1.710

8.  Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis.

Authors:  P Y Paterson; E D Day; C C Whitacre; R A Berenberg; D H Harter
Journal:  J Neurol Sci       Date:  1981-10       Impact factor: 3.181

9.  Interaction of multiple sclerosis serum with liposomes containing ganglioside GM1.

Authors:  B R Mullin; A J Montanaro; J D Reid; R N Nishimura
Journal:  Ann Neurol       Date:  1980-06       Impact factor: 10.422

10.  Blood group frequencies in multiple sclerosis populations in the United States.

Authors:  H B Warner; G S Merz; R I Carp
Journal:  Neurology       Date:  1980-06       Impact factor: 9.910

View more
  2 in total

1.  Altered serotonin uptake kinetics in multiple sclerosis.

Authors:  M Markianos; C Sfagos
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

2.  Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis.

Authors:  Roy A Garvin
Journal:  J Lipids       Date:  2015-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.